Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / ALRN - Aileron Therapeutics to Report Second Quarter 2019 Financial Results on August 6 2019

ALRN - Aileron Therapeutics to Report Second Quarter 2019 Financial Results on August 6 2019

Aileron Therapeutics Inc.

WATERTOWN, Mass., July 30, 2019 (GLOBE NEWSWIRE) -- Aileron Therapeutics (NASDAQ: ALRN), the clinical-stage leader in the field of stabilized cell-permeating peptides to treat cancer and other diseases, today announced that the Company will report financial results for its second quarter ended June 30, 2019 on Tuesday, August 6, 2019, after the close of the market.

About Aileron
Aileron is a clinical-stage biopharmaceutical company advancing a proprietary platform of cell-permeating alpha-helical peptides that address the most important intracellular targets in oncology and other therapeutic areas. The stabilized helical structure of our peptides allows the design of cell-permeating therapeutic agents with large molecular surfaces for optimal target binding properties, resulting in unique drugs like ALRN-6924. For more information, please visit www.aileronrx.com.

Investors:
Aileron Therapeutics
Don Dougherty, CFO
617-995-0900
ddougherty@aileronrx.com

Media:
Hans C. Vitzthum
LifeSci Advisors, LLC.
617-535-7743
hans@lifesciadvisors.com

Source: Aileron Therapeutics
Stock Information
Company Name: Aileron Therapeutics Inc.
Stock Symbol: ALRN
Market: NASDAQ
Website: aileronrx.com
Menu
ALRN ALRN Quote ALRN Short ALRN News ALRN Articles ALRN Message Board
Get ALRN Alerts

News, Short Squeeze, Breakout and More Instantly...